Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Yassine Tahri et al.|Blood|2021Cited by 0
Impact of Peri-Transplant Molecular Mutations Onoutcomes of AML Patients Undergoing Fludarabine/ Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Tsiporah B. Shore et al.|Transplantation and Cellular Therapy|2022Cited by 0